Get the Stockscreener App
2.88
6.49%
-0.20
After Hours:
2.88
Icecure Medical Ltd stock is traded at $2.88, with a volume of 78,426.
It is down -6.49% in the last 24 hours and down -51.68% over the past month.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
See More
Previous Close:
$3.08
Open:
$3.02
24h Volume:
78,426
Relative Volume:
0.03
Market Cap:
$9.87M
Revenue:
$3.57M
Net Income/Loss:
$-15.74M
P/E Ratio:
-0.4145
EPS:
-6.9481
Net Cash Flow:
$-15.77M
1W Performance:
-13.51%
1M Performance:
-51.68%
6M Performance:
-84.76%
1Y Performance:
-91.03%
1-Day Range:
$2.88
$3.24
1-Week Range:
$2.88
$3.40
52-Week Range:
$2.12
$42.00
Icecure Medical Ltd Stock (ICCM) Company Profile
Compare ICCM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
2.88 | 10.55M | 3.57M | -15.74M | -15.77M | -6.9481 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Icecure Medical Ltd Stock (ICCM) Latest News
IceCure Medical Kicks Off Post-Marketing ChoICE Study for ProSense Cryoablation in Low-Risk Breast Cancer Treatment at First U.S. Clinical Site - marketscreener.com
Icecure Medical Ltd (ICCM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Icecure Medical Ltd (ICCM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IceCure Medical launches U.S. post-marketing st... - Pluang
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site - PR Newswire
Icecure Medical Ltd (ICCM) Cash Flow - TradingKey
IceCure Medical Ltd. Revenue Breakdown – NASDAQ:ICCM - TradingView
Icecure Medical Ltd (ICCM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IceCure Medical (ICCM) Slumps 4.64% as Support Levels LoomPSAR Stop - dars.gov.et
ICCM|Icecure Medical Ltd|Price:3.080|Chg%:-0.150 - TradingKey
Icecure Medical Ltd|Price:3.080|Chg%:-0.150 - TradingKey
TradingKey - TradingKey
Why Has IceCure Medical's Stock Price Collapsed - Kavout | AI
Icecure Medical Ltd (ICCM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IceCure Medical Faces Sharp Decline: ICCM Drops 9.6% as Support Levels Are TestedLarge Cap Trends - dars.gov.et
Price to sales forward of IceCure Medical Ltd. – NASDAQ:ICCM - TradingView
Meir Peleg Net Worth (2026) - GuruFocus
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation - Sahm
ICCM: First FDA-cleared minimally invasive cryoablation device for breast cancer, driving global growth - TradingView
IceCure Medical (ICCM) Expands U.S. Team to Meet Growing Demand for ProSense® System - GuruFocus
IceCure Medical (ICCM) Expands Sales and Marketing Teams Nationw - GuruFocus
Enterprise value to revenue forward of IceCure Medical Ltd. – NASDAQ:ICCM - TradingView
IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer - AOL.com
IceCure Medical Ltd. emphasized that following FDA approval for breast cancer treatment, the commercial application of its Prosense™ cryoablation system is continuously expanding in Brazil. - Bitget
IceCure Medical (ICCM) Expands Presence in Brazil with ProSense System - GuruFocus
IceCure Medical Highlights Expanding Commercial Adoption Of ProSense Cryoablation In Brazil Following FDA Clearance For Breast Cancer - marketscreener.com
IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer - Barchart.com
[EFFECT] IceCure Medical Ltd. SEC Filing - Stock Titan
IceCure Medical (ICCM) Gains Ground: Support Holds, Resistance AheadMAMA Signal - DonanımHaber
Enterprise value to EBITDA forward of IceCure Medical Ltd. – NASDAQ:ICCM - TradingView
Price to earnings forward of IceCure Medical Ltd. – NASDAQ:ICCM - TradingView
Warrant repricing at IceCure Medical (NASDAQ: ICCM) heads to shareholder vote - Stock Titan
IceCure Medical Ltd. Actuals & Estimates (NASDAQ:ICCM) - TradingView
IceCure regains compliance with NASDAQ - MSN
IceCure regains compliance with Nasdaq MBP requirement - Medical Buyer
What's going on with IceCure Medical stock on Friday? - MSN
IceCure Medical Faces Certified Class Action Over 2021 Private Placement, Plans Court Challenge - The Globe and Mail
Why Is IceCure (NASDAQ:ICCM) Catching Small-Cap Attention? - Kalkine Media
IceCure Medical Ltd. Actuals & Estimates (BOATS:ICCM) - TradingView
[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer) | ICCM SEC FilingForm 6-K - Stock Titan
What's Going On With IceCure Medical Stock On Friday? - Benzinga
IceCure Medical Regains Nasdaq Compliance on Minimum Bid Price - The Globe and Mail
Icecure Medical(ICCM) Stock Options Chain | Quotes & News - Moomoo
IceCure Medical Files to Register Sale of 5.5 Million Shares by Armistice - marketscreener.com
ICCM: Selling Stockholders Plan to Offer 5.5 Million Shares - GuruFocus
IceCure Medical (ICCM) registers 5.5M shares tied to June 2026 warrants - Stock Titan
ICCM Forecast — Price Target — Prediction for 2027 - TradingView
IceCure Medical Ltd (ICCM) stock price, news, quote and history - Yahoo Finance Australia
IceCure Medical (Nasdaq: ICCM) back in compliance with bid price rule - Stock Titan
IceCure clears Nasdaq bid-price warning after 10-day run - Stock Titan
IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement - PR Newswire
Icecure Medical Ltd Stock (ICCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):